960531-75-3Relevant academic research and scientific papers
Tetracycline compounds
-
Page/Page column 321; 322; 323, (2016/05/19)
The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula I are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula I and its therapeutic use.
GLYCINE TRANSPORTER INHIBITING COMPOUNDS AND USES IN MEDICINE
-
Page/Page column 24-25, (2008/06/13)
Compounds of formula (I) and salts and solvates thereof are provided: wherein R1 and R2 are both methyl, or R1 and R2 form a pyrrolidinyl group. Uses in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, such as psych
GLYCINE TRANSPORTER INHIBITING COMPOUNDS AND USES IN MEDICINE
-
Page/Page column 24-25, (2008/06/13)
N-[[1-dimethylaminojcyclopentyl](phenyl)methyl]-4-fluoro-2-methyl-6- (methyloxy)benzamide:and salts and solvates thereof are provided. Uses in the manufacture of medicaments for treating neurological and neuropsychiatric disorders, such as psychoses, deme
